Persistent Depressive Disorder (PDD), historically known as dysthymia, affects approximately 1.5 percent of US adults in any given year and roughly 2.5 percent over a lifetime, according to the National Institute of Mental Health and the American Psychiatric Association's DSM-5-TR. The condition is less famous than Major Depressive Disorder but is arguably more insidious. Where MDD arrives in discrete episodes that can be clearly distinguished from a person's baseline, PDD is a low-grade depression that has been present for so long it starts to feel like personality. People with PDD often describe themselves as "just a pessimist" or "never really happy" without realizing that what they are describing is a diagnosable, treatable condition. The DSM-5 merged dysthymic disorder and chronic major depressive disorder into a single PDD category in 2013 because research published in the American Journal of Psychiatry showed that the two conditions were essentially indistinguishable in long-term outcomes and treatment response.

What Are the Official Criteria?

The DSM-5 requires eight criteria for a Persistent Depressive Disorder diagnosis. First, depressed mood for most of the day, for more days than not, for at least two years in adults (one year in children and adolescents). This duration rule is what distinguishes PDD from MDD. Second, the presence of two or more of the following six symptoms while depressed: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. Third, during the two-year period, the person has never been without the symptoms from criteria one and two for more than two months at a time. This continuity rule matters because PDD is defined by its chronicity. Fourth, the criteria for major depressive disorder may be continuously present for two years, in which case the diagnosis includes both PDD and MDD, sometimes called "double depression." Fifth, there has never been a manic or hypomanic episode. Sixth, the disturbance is not better explained by a persistent schizophrenia spectrum or other psychotic disorder. Seventh, the symptoms are not attributable to a substance or another medical condition. Eighth, the symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

How Is It Different From Major Depressive Disorder?

The core difference is duration and intensity. MDD is defined by discrete episodes lasting at least two weeks with five or more of nine specific symptoms. PDD is defined by persistent low-grade depression lasting at least two years with two or more of six symptoms. MDD is typically more severe but episodic. PDD is typically less severe but constant. The clinical problem with PDD is that the chronic nature hides the condition from the person experiencing it. A person who has felt mildly depressed for ten years has no recent memory of feeling well, so they assume their current state is their normal state. Research from James McCullough at Virginia Commonwealth University, whose Cognitive Behavioral Analysis System of Psychotherapy (CBASP) was developed specifically for chronic depression, found that PDD patients often struggle to imagine what "not depressed" would even feel like, and this imagination gap itself is a therapeutic target. The Harvard Review of Psychiatry has published multiple papers showing that PDD responds to treatment as well as MDD when the chronic nature is specifically addressed in therapy.

When Should You Seek Help?

Seek help if you have felt low-grade depressed for most days over at least two years and can identify at least two of the six secondary symptoms (appetite changes, sleep changes, fatigue, low self-esteem, concentration problems, hopelessness). The 2023 US Surgeon General advisory on loneliness identified chronic low-grade depression as a major contributor to social isolation because the sustained low mood erodes the small positive interactions that maintain relationships over time. Julianne Holt-Lunstad's longitudinal research on connection found that people with untreated chronic depression have significantly elevated mortality risk across the lifespan, comparable to the effects of heavy smoking. Treatments with the strongest evidence base for PDD include CBASP, cognitive behavioral therapy, interpersonal therapy, and antidepressant medication, often in combination. The APA's 2019 treatment guidelines specifically recommend combination therapy for chronic depression because response rates to single-modality treatment are lower than for acute MDD. The good news is that once treatment begins, many PDD patients describe the experience as finally seeing color after years of black and white. If this description resonates, the two-year rule in the DSM-5 is not a sentence. It is a doorway.